Company / Profit Margin
Bionano Genomics, Inc. Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-92.6%
FY2025
5-year range
-643.7% / -92.6%
FY2021-FY2025
Trend
+85.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 8 years, ranging from -643.7% in FY2024 to -92.6% in FY2025.
Based on SEC 10-K filings.
-92.6% in FY2025 with a 5-year CAGR of +201.8%.
Improved from -476.9% to -92.6% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +384.3pp
- 5-Year Change
- +201.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 85.6% year-over-year.
- Lowest profit margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -92.6% | +85.6% |
| FY2024 | -643.7% | -35.0% |
| FY2023 | -476.9% | +0.0% |
| FY2022 | -476.9% | +1.3% |
| FY2021 | -483.4% | -64.2% |
| FY2020 | -294.3% | -91.0% |
| FY2019 | -154.1% | +37.3% |
| FY2018 | -245.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026